Just some food for thought, IMO I believe this news drop has begun the phase whereby RAC is a true contender in the oncology space by delivering from its initial claims to potentially curing cancer to actually releasing strong empirical evidence.
Alongside the news coming in the upcoming week, I feel as though RAC’s position is truly beginning to solidify as it begins to emerge on its two feet in preparation to fight cancer with Bisantrene. bravo and hats off to the team at RAC.
Ann: Compelling Preclinical Breast Cancer Results, page-150
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
-0.050(3.17%) |
Mkt cap ! $259.9M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.59 | $1.51 | $174.6K | 113.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2372 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 141 | 1 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |